canerpaturev (TBI-1401) - Takara
Oncorine (recombinant human adenovirus type 5) - Mergen Ltd.
Imlygic (talimogene laherparepvec) - Amgen
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/40329730
 
Run-Bin Tan; Yeannie Hui-Yeng Yap
 
May 7, 2025
 
Next